By Jonathan Gardner | Published Sept. 3, 2026 The landscape of lung cancer treatment, already fundamentally reshaped...
Treatment Innovations
For decades, the field of cell biology has been constrained by a persistent optical paradox. Scientists have...
As the industry transitions out of the summer season and into the final quarter of 2026, the...
By Delilah Alvarado Published September 3, 2026 In a significant strategic move to solidify its position in...
In a significant leap forward for diagnostic cardiology, Tennessee-based medical technology firm Heartvue.ai has announced that its...
In a significant move that underscores the rapid evolution of digital health, Boston-based medical technology firm Elucid...
In a sterile, high-tech manufacturing facility in Raritan, New Jersey, a profound intersection of humanity and biotechnology...
In an era defined by evolving global security threats and the urgent need for resilient medical infrastructure,...
In a significant leap forward for neurological diagnostics in North America, Fujirebio—a wholly owned subsidiary of HU...
In the high-stakes world of pharmaceutical development, where a single phase 3 oncology trial can determine the...
